Centene Corp. (CNC): Price and Financial Metrics
GET POWR RATINGS... FREE!
CNC POWR Grades
- Growth is the dimension where CNC ranks best; there it ranks ahead of 97.34% of US stocks.
- CNC's strongest trending metric is Sentiment; it's been moving up over the last 179 days.
- CNC ranks lowest in Momentum; there it ranks in the 38th percentile.
CNC Stock Summary
- With a market capitalization of $49,502,798,339, Centene Corp has a greater market value than 94.5% of US stocks.
- The capital turnover (annual revenue relative to shareholder's equity) for CNC is 4.7 -- better than 91.4% of US stocks.
- CNC's price/sales ratio is 0.39; that's higher than the P/S ratio of merely 8.24% of US stocks.
- If you're looking for stocks that are quantitatively similar to Centene Corp, a group of peers worth examining would be JCI, HUM, COF, DG, and ECL.
- Visit CNC's SEC page to see the company's official filings. To visit the company's web site, go to www.centene.com.
CNC Valuation Summary
- In comparison to the median Healthcare stock, CNC's price/sales ratio is 97.36% lower, now standing at 0.3.
- Over the past 240 months, CNC's EV/EBIT ratio has gone up 17.3.
- CNC's price/earnings ratio has moved up 36.2 over the prior 240 months.
Below are key valuation metrics over time for CNC.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
CNC | 2021-08-31 | 0.3 | 1.4 | 51.0 | 23.6 |
CNC | 2021-08-30 | 0.3 | 1.4 | 51.2 | 23.6 |
CNC | 2021-08-27 | 0.3 | 1.4 | 51.8 | 23.9 |
CNC | 2021-08-26 | 0.3 | 1.4 | 51.5 | 23.8 |
CNC | 2021-08-25 | 0.3 | 1.4 | 51.5 | 23.8 |
CNC | 2021-08-24 | 0.3 | 1.5 | 52.3 | 24.1 |
CNC Growth Metrics
- Its 2 year net income to common stockholders growth rate is now at -17.88%.
- Its 5 year net income to common stockholders growth rate is now at 207.27%.
- Its 4 year revenue growth rate is now at 234.47%.

The table below shows CNC's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2021-12-31 | 125,982 | 4,205 | 1,347 |
2021-09-30 | 121,702 | 6,511 | 736 |
2021-06-30 | 118,386 | 3,757 | 720 |
2021-03-31 | 115,073 | 5,786 | 2,461 |
2020-12-31 | 111,115 | 5,503 | 1,808 |
2020-09-30 | 101,690 | 1,871 | 2,029 |
CNC's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CNC has a Quality Grade of C, ranking ahead of 69.88% of graded US stocks.
- CNC's asset turnover comes in at 1.689 -- ranking 4th of 133 Insurance stocks.
- JRVR, CIA, and AXS are the stocks whose asset turnover ratios are most correlated with CNC.
The table below shows CNC's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 1.689 | 0.114 | 0.062 |
2021-06-30 | 1.698 | 0.119 | 0.068 |
2021-03-31 | 1.669 | 0.136 | 0.167 |
2020-12-31 | 1.635 | 0.137 | 0.138 |
2020-09-30 | 1.666 | 0.138 | 0.157 |
2020-06-30 | 1.744 | 0.133 | 0.147 |
CNC Price Target
For more insight on analysts targets of CNC, see our CNC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $83.10 | Average Broker Recommendation | 1.43 (Moderate Buy) |
CNC Stock Price Chart Interactive Chart >
CNC Price/Volume Stats
Current price | $86.21 | 52-week high | $89.92 |
Prev. close | $84.61 | 52-week low | $59.67 |
Day low | $83.56 | Volume | 1,972,800 |
Day high | $86.39 | Avg. volume | 2,900,130 |
50-day MA | $82.23 | Dividend yield | N/A |
200-day MA | $78.53 | Market Cap | 50.42B |
Centene Corp. (CNC) Company Bio
Centene Corporation is a publicly traded managed care company based in St. Louis, Missouri. It serves as an intermediary for government-sponsored and privately insured health care programs. Centene ranked No. 24 on the 2021 Fortune 500 . (Source:Wikipedia)
Latest CNC News From Around the Web
Below are the latest news stories about Centene Corp that investors may wish to consider to help them evaluate CNC as an investment opportunity.
Select Medical (SEM) Q4 Earnings Beat on Higher AdmissionsSelect Medical's (SEM) fourth-quarter results reflect solid revenues driven by robust contributions from all its segments, partly offset by higher costs and expenses. |
Centene CEO Michael Neidorff takes medical leaveThe company named board member James Dallas as acting chairman, and said it expects to appoint a new CEO no later than the second quarter of this year. In December, the company had reached a deal with activist investment firm Politan Capital Management under which Neidorff was expected to retire this year after serving for a quarter of a century. Centene in July laid the groundwork for a succession plan when it established its office of the president and Neidorff, the CEO since 1996, said in public that he would not expect to be renewing his contract as the chief. |
CENTENE ANNOUNCES APPROVAL OF REQUEST BY MICHAEL NEIDORFF, CHAIRMAN & CEO, TO TAKE A MEDICAL LEAVE OF ABSENCECentene Corporation (NYSE: CNC) ("Centene") announced today that its Board of Directors approved a request from Michael Neidorff, Chairman & Chief Executive Officer, for a medical leave of absence. James Dallas has been named Acting Chairman of the Board. |
Teladoc (TDOC) Unveils Solution to Ease Whole-Person CareTeladoc Health (TDOC) launches Chronic Care Complete for extending a comprehensive suite of chronic condition management services for serving the whole-person health needs of eligible members. |
UnitedHealth Group (UNH) Bolsters Presence With Contract WinUnitedHealth Group's (UNH) unit UnitedHealthcare receives a contract from the District of Columbia aimed at improving health outcomes of District Dual Choice program enrollees in the district. |
CNC Price Returns
1-mo | 5.17% |
3-mo | -1.04% |
6-mo | 12.93% |
1-year | N/A |
3-year | 67.46% |
5-year | 116.34% |
YTD | 4.62% |
2021 | 37.26% |
2020 | -4.52% |
2019 | 9.05% |
2018 | 14.29% |
2017 | 78.52% |
Continue Researching CNC
Want to do more research on Centene Corp's stock and its price? Try the links below:Centene Corp (CNC) Stock Price | Nasdaq
Centene Corp (CNC) Stock Quote, History and News - Yahoo Finance
Centene Corp (CNC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...